Table 7.

Crosstabulation chemotherapy/tumor entity

			Tumor entity					Total
			ALT	DLS	MLS	PLS	LSM
Chemotherapy	Yes	Number of patients	0	5	6	6	0	17
		% of chemotherapy	0,0%	29,4%	35,3%	35,3%	0,0%	100,0%
	No	Number of patients	56	16	32	6	1	111
		% of chemotherapy	50,5%	14,4%	28,8%	5,4%	0,9%	100,0%
Total		Number of patients	56	21	38	12	1	128
		% of chemotherapy	43,8%	16,4%	29,7%	9,4%	0,8%	100,0%

ALT Atypical lipomatous tumour, DLS Dedifferentiated liposarcoma, MLS Myxoid liposarcoma, PLS Pleomorphic liposarcoma, LSM Mixed-type liposarcoma